NFKB1 and gastric cancer: We previously demonstrated that inhibition of NF-κB activity by treatment of antisense oligodeoxynucleotide (ODN) for NF-κB subunit p50 or transfection of a mutated IκBα gene (MAD-3 mutant) inhibited cell growth of human gastric cancer AGS cells.